Sociodemographic, clinical and laboratory profile of trans women and transvesti undergoing hormone therapy in the SUS: a cross-sectional study at Casarão da Diversidade Salvador, Bahia
DOI:
https://doi.org/10.34119/bjhrv8n3-241Keywords:
hormone therapy, cardiometabolism, pharmacotherapyAbstract
This cross-sectional study analyzed the sociodemographic, clinical, and laboratory profiles of trans women and travestis assisted by a public health service in Salvador, Bahia. The sample included 81 participants aged 18 or older who underwent laboratory testing and answered a structured questionnaire. Participants were divided into three groups: current hormone therapy use, previous use, and never used. The average age was 27.8 years, with a predominance of Black, single individuals with low income and education. The most used hormones were Perlutan and combinations of injectable and oral estrogens. The current hormone therapy group had lower body mass index, abdominal circumference, and fasting glucose levels. The group with prior use had higher systolic blood pressure and uric acid levels. No significant differences were observed in hepatic markers or lipid profile. Findings suggest that, among young and healthy populations, hormone therapy is not associated with clinically significant laboratory alterations. Nonetheless, professional follow-up and longitudinal studies are necessary to evaluate long-term metabolic, hepatic, cardiovascular, and renal effects.
References
AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, Text Revision (DSM-5-TR). Washington, DC: American Psychiatric Association, 2022.
ANGUS, L. M. et al. Effect of Spironolactone and Cyproterone Acetate on Breast Growth in Transgender People: A Randomized Clinical Trial. J. Clin. Endocrinol. Metab., v. 110, n. 6, p. e1874–84, 19 maio 2025. Disponível em: https://doi.org/10.1210/clinem/dgae650. Acesso em: 9 jun. 2025.
COCCHETTI, C. et al. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI). J. Sex Med., v. 18, n. 5, p. 821–9, maio 2021. Disponível em: https://doi.org/10.1016/j.jsxm.2021.02.005. Acesso em: 9 jun. 2025.
COSTA, A. et al. Healthcare Needs of and Access Barriers for Brazilian Transgender and Gender Diverse People. J. Immigr. Minor Health, v. 20, n. 1, p. 115–23, 2018. Disponível em: https://doi.org/10.1007/s10903-016-0527-7. Acesso em: 9 jun. 2025.
DEUTSCH, M. B.; BHAKRI, V.; KUBICEK, K. Effects of cross-sex hormone treatment on transgender women and men. Obstet. Gynecol., v. 125, n. 3, p. 605–10, mar. 2015. Disponível em: https://doi.org/10.1097/AOG.0000000000000692. Acesso em: 9 jun. 2025.
DUARTE, M. F. S. Maturação física: uma revisão da literatura, com especial atenção à criança brasileira. Cad. Saúde Pública, v. 9, supl. 1, p. S71–84, 1993. Disponível em: https://doi.org/10.1590/S0102-311X1993000500008. Acesso em: 9 jun. 2025.
ELBERS, J. M. et al. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin. Endocrinol. (Oxf.), v. 58, n. 5, p. 562–71, maio 2003. Disponível em: https://doi.org/10.1046/j.1365-2265.2003.01753.x. Acesso em: 9 jun. 2025.
GALMÉS-PASCUAL, B. M. et al. 17β-estradiol ameliorates lipotoxicity-induced hepatic mitochondrial oxidative stress and insulin resistance. Free Radic. Biol. Med., v. 150, p. 148–60, 20 fev. 2020. Disponível em: https://doi.org/10.1016/j.freeradbiomed.2020.02.016. Acesso em: 9 jun. 2025.
KING, W. M. et al. Racial/ethnic differences in the association between transgender-related U.S. state policies and self-rated health of transgender women. BMC Public Health, v. 24, n. 1, p. 911, 22 abr. 2024. Disponível em: https://doi.org/10.1186/s12889-024-18317-z. Acesso em: 9 jun. 2025.
KLAVER, M. et al. Cross-sex hormone therapy in transgender persons affects total body weight, body fat and lean body mass: a meta-analysis. Andrologia, v. 49, n. 5, p. e12660, fev. 2017. Disponível em: https://doi.org/10.1111/and.12660. Acesso em: 9 jun. 2025.
MAUVAIS-JARVIS, F.; CLEGG, D. J.; HEVENER, A. L. The role of estrogens in control of energy balance and glucose homeostasis. Endocr. Rev., v. 34, n. 3, p. 309–38, jun. 2013. Disponível em: https://doi.org/10.1210/er.2012-1055. Acesso em: 9 jun. 2025.
MILIONIS, C.; ILIAS, I.; KOUKKOU, E. Liver function in transgender persons: Challenges in the COVID-19 era. World J. Clin. Cases, v. 11, n. 2, p. 299–307, 16 jan. 2023. Disponível em: https://doi.org/10.12998/wjcc.v11.i2.299. Acesso em: 9 jun. 2025.
NARVAZ, M. G.; KOLLER, S. H. Metodologias feministas e estudos de Gênero: Articulando pesquisa, clínica e política. Psicol. Estud., v. 11, n. 3, p. 647–54, 2006. Disponível em: https://doi.org/10.1590/S1413-73722006000300021. Acesso em: 9 jun. 2025.
NGUYEN, H. B. et al. Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition. Curr. Psychiatry Rep., v. 20, n. 12, p. 110, 11 out. 2018. Disponível em: https://doi.org/10.1007/s11920-018-0973-0. Acesso em: 9 jun. 2025.
ROCON, P. C. et al. Gender affirmation in the lives of trans people: from suffering to health. Interface (Botucatu), v. 22, n. 64, p. 29–40, 2018. Disponível em: https://doi.org/10.1590/1807-57622016.0712. Acesso em: 9 jun. 2025.
SUPPAKITJANUSANT, P. et al. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study. J. Clin. Transl. Endocrinol., v. 19, p. 100230, mar. 2020. Disponível em: https://doi.org/10.1016/j.jcte.2020.100230. Acesso em: 9 jun. 2025.
VELZEN, D. M. et al. Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen. J. Clin. Endocrinol. Metab., v. 104, n. 6, p. 1937–47, 1 jun. 2019. Disponível em: https://doi.org/10.1210/jc.2018-02138. Acesso em: 9 jun. 2025.
WINTER, S. et al. Transgender people: health at the margins of society. Lancet, v. 388, n. 10042, p. 390–400, 23 jul. 2016. Disponível em: https://doi.org/10.1016/S0140-6736(16)00683-8. Acesso em: 9 jun. 2025.
WITTLIN, N. M.; KUPER, L. E.; OLSON, K. R. Mental Health of Transgender and Gender Diverse Youth. Annu. Rev. Clin. Psychol., v. 19, p. 207–32, 9 maio 2023. Disponível em: https://doi.org/10.1146/annurev-clinpsy-072220-020326. Acesso em: 9 jun. 2025.
